Dashboard
Manage Tickers

FCTESMI 3Fourteen Full-Cycle Tr...


$ 26.20 $ 0.34 (1.29 %)    

Thursday, 12-Sep-2024 15:27:35 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 26.55
$ 26.54 x 100
-- x --
-- - --
$ 24.46 - $ 27.31
31,048
na
na
$ 0.03
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

economic-headwinds-impact-graingers-top-line-q2-results-mixed
Economic Headwinds Impact Grainger's Top L...
08/01/2024 13:50:39

Grainger reported lower Q2 FY24 results with sales of $4.312 billion, missing consensus. Adjusted EPS beat at $9.76. Outlook na...

cdw-misses-q2-estimates-amid-challenging-it-spending-environment
CDW Misses Q2 Estimates Amid Challenging I...
07/31/2024 16:51:06

CDW Corporation reported worse-than-expected Q2 FY24 results, with net sales down and EPS missing consensus.

builder-dr-horton-beats-on-q3-earnings-authorizes-4b-stock-buyback-tightens-fy24-home-sales-forecast--more
Builder D.R. Horton Beats On Q3 Earnings, ...
07/18/2024 17:23:23

D.R. Horton reported Q3 FY24 results with sales of $10.0B (+2% Y/Y) and EPS of $4.10 (+5% Y/Y). The company also announced a ne...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION